Lantheus Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
Lantheus Holdings, Inc. (LNTH) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2023-05-04
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2023-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-09-30 was 455.00K shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-06-30 was 443.00K shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-03-31 was 406.00K shares, a 395.12% increase year-over-year.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 439.00K shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2021 was 0.00 shares.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2020 was 0.00 shares, a 100.00% decline from fiscal 2019.
- Lantheus Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2019 was 75.00K shares, a 22.95% increase from fiscal 2018.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month as first filed | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 6 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-04 | |||||
| 2022-12-31 | 439.00K shares 10-K · filed 2023-02-23 | |||||
| 2022-09-30 | 455.00K shares 10-Q · filed 2022-11-03 | 452.00K shares 10-Q · filed 2022-11-03 | ||||
| 2022-06-30 | 443.00K shares 10-Q · filed 2022-08-04 | 441.00K shares 10-Q · filed 2022-08-04 | ||||
| 2022-03-31 | 406.00K shares 10-Q · filed 2023-05-04 | |||||
| 2021-12-31 | 0.00 shares 10-K · filed 2023-02-23 | |||||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-03 | 0.00 shares 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-04 | 0.00 shares 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 82.00K shares 10-Q · filed 2022-04-29 | |||||
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-23 | |||||
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-05 | 0.00 shares 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-07-28 | 0.00 shares 10-Q · filed 2021-07-28 | ||||
| 2020-03-31 | 28.00K shares 10-Q · filed 2021-05-04 | |||||
| 2019-12-31 | 75.00K shares 10-K · filed 2022-02-24 | |||||
| 2019-09-30 | 85.00K shares 10-Q · filed 2020-11-05 | 82.00K shares 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | 98.00K shares 10-Q · filed 2020-07-31 | 80.00K shares 10-Q · filed 2020-07-31 | ||||
| 2019-03-31 | 58.00K shares 10-Q · filed 2020-04-30 | |||||
| 2018-12-31 | 61.00K shares 10-K · filed 2021-02-25 | 1.21M shares 10-K · filed 2019-02-20 | ||||
| 2018-09-30 | 31.00K shares 10-Q · filed 2019-10-31 | 70.00K shares 10-Q · filed 2019-10-31 | ||||
| 2018-06-30 | 37.00K shares 10-Q · filed 2019-07-25 | 90.00K shares 10-Q · filed 2019-07-25 | ||||
| 2018-03-31 | 150.00K shares 10-Q · filed 2019-04-30 | |||||
| 2017-12-31 | 1.33M shares 10-K · filed 2019-02-20 | 32.00K shares 10-K · filed 2018-02-26 | ||||
| 2017-09-30 | 318.00K shares 10-Q · filed 2018-10-30 | 371.00K shares 10-Q · filed 2018-10-30 | ||||
| 2017-06-30 | 324.00K shares 10-Q · filed 2018-08-01 | 347.00K shares 10-Q · filed 2018-08-01 | ||||
| 2017-03-31 | 303.00K shares 10-Q · filed 2018-05-02 | 302.99K shares 10-Q · filed 2017-05-02 | ||||
| 2016-12-31 | 0.00 shares 10-K · filed 2019-02-20 | |||||
| 2016-09-30 | 1.08M shares 10-Q · filed 2017-11-02 | 391.00K shares 10-Q · filed 2017-11-02 | ||||
| 2016-06-30 | 165.00K shares 10-Q · filed 2017-08-01 | 81.00K shares 10-Q · filed 2017-08-01 | ||||
| 2016-03-31 | 0.00 shares 10-Q · filed 2017-05-02 | |||||
| 2015-12-31 | 0.00 shares 10-K · filed 2018-02-26 | |||||
| 2015-09-30 | 112.34K shares 10-Q · filed 2016-11-01 | |||||
| 2015-03-31 | 323.45K shares 10-Q · filed 2016-05-03 | |||||
| 2014-12-31 | 0.00 shares 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |